info@eppinpharma.com

Eppin Pharma Inc
Eppin Pharma Inc
  • Home
  • How Eppin Works
  • Our Story
  • Leadership
  • Publications
  • In the News
  • FCOI policy
  • More
    • Home
    • How Eppin Works
    • Our Story
    • Leadership
    • Publications
    • In the News
    • FCOI policy

info@eppinpharma.com


  • Home
  • How Eppin Works
  • Our Story
  • Leadership
  • Publications
  • In the News
  • FCOI policy

Important Publications

2001

2001

2001

Cloning and sequencing of human Eppin: a novel family of protease inhibitors expressed in the epididymis and testis.

Richardson RT, Sivashanmugam P, Hall SH, Hamil KG, Moore PA, Ruben SM, et al.

Gene. 2001 May 30;270(1–2):93–102. PMID:11404006

doi.org/10.1016/S0378-1119(01)00462-0 

2004

2001

2001

Antimicrobial activity of human EPPIN, an androgen-regulated, sperm-bound protein with a whey acidic protein motif.

Yenugu S, Richardson RT, Sivashanmugam P, Wang Z, O'Rand MG, French FS, Hall SH.

Biol Reprod. 2004 Nov;71(5):1484-90. Epub 2004 Jun 30. PMID:15229136

 DOI: 10.1095/biolreprod.104.031567 

2004

2001

2004

Reversible immunocontraception in male monkeys immunized with eppin.

O'Rand MG, Widgren EE, Sivashanmugam P, Richardson RT, Hall SH, French FS, VandeVoort CA, Ramachandra SG, Ramesh V, Jagannadha Rao A.

Science. 2004 Nov 12;306(5699):1189-90. PMID:15539605 

DOI: 10.1126/science.1099743 

2005

2005

2004

Association of eppin with semenogelin on human spermatozoa.

Wang Z, Widgren EE, Sivashanmugam P, O'Rand MG, Richardson RT.

Biol Reprod. 2005 May;72(5):1064-70. Epub 2004 Dec 8. PMID:15590901

DOI: 10.1095/biolreprod.104.036483 

2007

2005

2007

Characterization of an eppin protein complex from human semen and spermatozoa.

Wang Z, Widgren EE, Richardson RT, O'Rand MG.

Biol Reprod. 2007 Sep;77(3):476-84. Epub 2007 Jun 13. PMID:17567961

DOI: 10.1095/biolreprod.107.060194 

2009

2005

2007

Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate.

O'Rand MG, Widgren EE, Beyler S, Richardson RT.

Biol Reprod. 2009 Feb;80(2):279-85. Epub 2008 Oct 22. PMID: 18945989

DOI: 10.1095/biolreprod.108.072942 

2010

2010

2010

Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.

Mitra A, Richardson RT, O'Rand MG.

Biol Reprod. 2010 Mar;82(3):489-96. Epub 2009 Nov 4.PMID: 19889947

DOI: 10.1095/biolreprod.109.081331 

2011

2010

2010

Epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive.

O’Rand MG, Widgren EE, Hamil KG, Silva EJ, Richardson RT. J Androl. 2011 Dec;32(6):698–704. Epub 2011 Mar 25. Review. PMID: 21441428

DOI: 10.2164/jandrol.110.012781 

2012

2010

2012

Loss of calcium in human spermatozoa via EPPIN, the semenogelin receptor.

O'Rand MG, Widgren EE Biol Reprod. 2012 Feb 29;86(2):55. doi: 10.1095/biolreprod.111.094227. Print 2012 Feb. PMID: 22075473 

DOI: 10.1095/biolreprod.112.101832 

2012

2012

2012

Characterization of EPPIN's semenogelin I binding site: a contraceptive drug target.

Silva EJR, Hamil KG, Richardson RT, O’Rand MG.

Biol Reprod. 2012 Sep;87(3):56, Print 2012 Sep. PMID:22699487

DOI: 10.1095/biolreprod.112.101832 

2013

2012

2013

Interacting proteins on human spermatozoa: adaptive evolution of the binding of semenogelin I to EPPIN.

Silva EJR, Hamil KG, O’Rand MG.. PloS One. 2013;8(12):e82014. eCollection 2013. PMID:24312623.

DOI: 10.1371/journal.pone.0082014 

2016

2012

2013

Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

O’Rand MG, Silva EJR, Hamil KG. 

Pharmacol Ther. 2016 Jan;157:105–11. PMID: 26593445

DOI: 10.1016/j.pharmthera.2015.11.004 

2018

2018

2018

Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive

Michael G. O’Rand, Katherine G. Hamil, Tiffany Adevai, Mary Zelinski

PLOS One April 19 2018

 PMCID:               PMC5908160      

DOI:               10.1371/journal.pone.0195953       

2023

2018

2018

 Interactions of the male

contraceptive target EPPIN

with semenogelin‑1 and small

organic ligands

Antoniel A. S. Gomes, Natália C. M. Santos, Leonardo R. Rosa, Rafael J. Borges 

Scientific Reports | (2023) 13:14382  https://doi.org/10.1038/s41598-023-41365-1

Go to PubMed

also check out the Male Contraceptive Initiative Website

Male Contraception Initiative works with researchers across the globe to make male contraceptive options a reality.

go to the MCI website

Copyright © 2018 Eppin Pharma Inc - All Rights Reserved.


Powered by GoDaddy

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept & Close